Merck Serono Launches Strategic Venture Capital Fund
New Venture Capital Fund Will Invest in Biotech Start-up Companies
25-Mar-2009 -
Merck Serono, a division of Merck KGaA, announced the formation of Merck Serono Ventures, a strategic, corporate venture capital fund to invest in emerging biotechnology companies. The fund will support biotech start-up companies that have the potential to provide innovative products in Merck ...
biotechnology
diseases
inflammation
+3